Loading...

Harmonicare Medical Holdings

SEHK:1509
Snowflake Description

Reasonable growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
1509
SEHK
HK$2B
Market Cap
  1. Home
  2. HK
  3. Healthcare
Company description

Harmonicare Medical Holdings Limited, an investment holding company, operates obstetrics and gynecology hospitals that provide inpatient and outpatient healthcare services. The last earnings update was 50 days ago. More info.


Add to Portfolio Compare Print
1509 Share Price and Events
7 Day Returns
0%
SEHK:1509
-3.9%
HK Healthcare
-0.2%
HK Market
1 Year Returns
-2.9%
SEHK:1509
-22.1%
HK Healthcare
-6.6%
HK Market
1509 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Harmonicare Medical Holdings (1509) 0% 0% 2% -2.9% -45.6% -
HK Healthcare -3.9% -4% -14.4% -22.1% -28.6% -11.2%
HK Market -0.2% 2.3% -5.5% -6.6% 22.5% 4.4%
1 Year Return vs Industry and Market
  • 1509 outperformed the Healthcare industry which returned -22.1% over the past year.
  • 1509 outperformed the Market in Hong Kong which returned -6.6% over the past year.
Price Volatility
1509
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Harmonicare Medical Holdings's competitors could be found in our database.

Value

 Is Harmonicare Medical Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Harmonicare Medical Holdings. This is due to cash flow or dividend data being unavailable. The share price is HK$2.04.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Harmonicare Medical Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Harmonicare Medical Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:1509 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CNY CN¥-0.27
SEHK:1509 Share Price ** SEHK (2019-03-29) in HKD HK$2.04
SEHK:1509 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.881 CN¥1.8
Hong Kong Healthcare Industry PE Ratio Median Figure of 20 Publicly-Listed Healthcare Companies 15.99x
Hong Kong Market PE Ratio Median Figure of 1,488 Publicly-Listed Companies 10.77x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Harmonicare Medical Holdings.

SEHK:1509 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:1509 Share Price ÷ EPS (both in CNY)

= 1.8 ÷ -0.27

-6.68x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Harmonicare Medical Holdings is loss making, we can't compare its value to the HK Healthcare industry average.
  • Harmonicare Medical Holdings is loss making, we can't compare the value of its earnings to the Hong Kong market.
Price based on expected Growth
Does Harmonicare Medical Holdings's expected growth come at a high price?
Raw Data
SEHK:1509 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.68x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
44%per year
Hong Kong Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.02x
Hong Kong Market PEG Ratio Median Figure of 470 Publicly-Listed Companies 0.77x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Harmonicare Medical Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Harmonicare Medical Holdings's assets?
Raw Data
SEHK:1509 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CNY CN¥1.49
SEHK:1509 Share Price * SEHK (2019-03-29) in HKD HK$2.04
SEHK:1509 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.881 CN¥1.8
Hong Kong Healthcare Industry PB Ratio Median Figure of 36 Publicly-Listed Healthcare Companies 1.59x
Hong Kong Market PB Ratio Median Figure of 2,173 Publicly-Listed Companies 0.93x
SEHK:1509 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:1509 Share Price ÷ Book Value per Share (both in CNY)

= 1.8 ÷ 1.49

1.21x

* Primary Listing of Harmonicare Medical Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Harmonicare Medical Holdings is good value based on assets compared to the HK Healthcare industry average.
X
Value checks
We assess Harmonicare Medical Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Harmonicare Medical Holdings has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Harmonicare Medical Holdings expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

  • No analysts cover Harmonicare Medical Holdings, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
44%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Harmonicare Medical Holdings expected to grow at an attractive rate?
  • Harmonicare Medical Holdings's earnings growth is expected to exceed the low risk savings rate of 2%.
Growth vs Market Checks
  • Harmonicare Medical Holdings's earnings growth is expected to exceed the Hong Kong market average.
  • Harmonicare Medical Holdings's revenue growth is expected to exceed the Hong Kong market average.
Annual Growth Rates Comparison
Raw Data
SEHK:1509 Future Growth Rates Data Sources
Data Point Source Value (per year)
SEHK:1509 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 44%
SEHK:1509 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 12.3%
Hong Kong Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.5%
Hong Kong Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 12.7%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average 11.1%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 10.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:1509 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CNY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:1509 Future Estimates Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 1,297 1
2019-12-31 1,206 1
SEHK:1509 Past Financials Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income *
2018-12-31 1,009 -199
2018-09-30 1,009 -104
2018-06-30 1,010 -3 -9
2018-03-31 967 8 9
2017-12-31 924 19 27
2017-09-30 888 39 47
2017-06-30 853 59 67
2017-03-31 856 83 81
2016-12-31 860 106 96
2016-09-30 877 101 102
2016-06-30 894 97 108
2016-03-31 902 111 107

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Harmonicare Medical Holdings's earnings are expected to grow significantly at over 20% yearly.
  • Harmonicare Medical Holdings's revenue is expected to grow by 12.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:1509 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Harmonicare Medical Holdings Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:1509 Future Estimates Data
Date (Data in CNY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31
2019-12-31
SEHK:1509 Past Financials Data
Date (Data in CNY Millions) EPS *
2018-12-31 -0.27
2018-09-30 -0.14
2018-06-30 -0.01
2018-03-31 0.01
2017-12-31 0.04
2017-09-30 0.06
2017-06-30 0.09
2017-03-31 0.11
2016-12-31 0.13
2016-09-30 0.13
2016-06-30 0.14
2016-03-31 0.15

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Harmonicare Medical Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Harmonicare Medical Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Harmonicare Medical Holdings has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Harmonicare Medical Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Harmonicare Medical Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Harmonicare Medical Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Harmonicare Medical Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Harmonicare Medical Holdings's 1-year growth to the HK Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Harmonicare Medical Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Harmonicare Medical Holdings Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:1509 Past Revenue, Cash Flow and Net Income Data
Date (Data in CNY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 1,008.90 -198.76 554.37
2018-09-30 1,009.46 -104.01 499.15
2018-06-30 1,010.03 -9.27 443.94
2018-03-31 967.09 9.06 412.63
2017-12-31 924.15 27.39 381.33
2017-09-30 888.37 47.10 361.30
2017-06-30 852.59 66.81 341.28
2017-03-31 856.15 81.26 339.69
2016-12-31 859.70 95.71 338.11
2016-09-30 877.01 101.91 342.10
2016-06-30 894.33 108.10 346.09
2016-03-31 901.84 107.14 336.94
2015-12-31 909.36 106.17 327.78
2015-09-30 917.27 101.83 320.42
2015-06-30 925.17 97.49 313.07
2015-03-31 930.50 100.43 317.93
2014-12-31 935.84 103.38 322.79
2013-12-31 833.20 66.84 294.14
2012-12-31 750.26 30.57 310.29

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Harmonicare Medical Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Harmonicare Medical Holdings has efficiently used its assets last year compared to the HK Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Harmonicare Medical Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Harmonicare Medical Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Harmonicare Medical Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Harmonicare Medical Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Harmonicare Medical Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Harmonicare Medical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Harmonicare Medical Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Harmonicare Medical Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 4.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Harmonicare Medical Holdings Company Filings, last reported 5 months ago.

SEHK:1509 Past Debt and Equity Data
Date (Data in CNY Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 1,240.27 80.40 130.30
2018-09-30 1,240.27 80.40 130.30
2018-06-30 1,473.88 0.92 248.19
2018-03-31 1,473.88 0.92 248.19
2017-12-31 1,582.11 0.50 512.00
2017-09-30 1,582.11 0.50 512.00
2017-06-30 1,356.61 0.66 840.45
2017-03-31 1,356.61 0.66 840.45
2016-12-31 1,383.38 4.50 1,067.00
2016-09-30 1,383.38 4.50 1,067.00
2016-06-30 1,382.51 0.00 1,201.92
2016-03-31 1,382.51 0.00 1,201.92
2015-12-31 1,410.97 0.00 1,222.98
2015-09-30 1,410.97 0.00 1,222.98
2015-06-30 218.93 0.00 61.59
2015-03-31 218.93 0.00 61.59
2014-12-31 -99.50 0.00 72.06
2013-12-31 -67.21 0.00 10.75
2012-12-31 -3.13 0.00 14.08
  • Harmonicare Medical Holdings's level of debt (6.5%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 6.5% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on Harmonicare Medical Holdings's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Harmonicare Medical Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Harmonicare Medical Holdings has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Harmonicare Medical Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Harmonicare Medical Holdings dividends. Estimated to be 0% next year.
If you bought HK$2,000 of Harmonicare Medical Holdings shares you are expected to receive HK$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Harmonicare Medical Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Harmonicare Medical Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:1509 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Hong Kong Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 13 Stocks 2.6%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 966 Stocks 3.7%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.2%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2.1%
Hong Kong Top 25% Dividend Yield 75th Percentile 5.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:1509 Future Dividends Estimate Data
Date (Data in CN¥) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00
SEHK:1509 Past Annualized Dividends Data
Date (Data in CN¥) Dividend per share (annual) Avg. Yield (%)
2018-09-18 0.000 0.000
2018-08-30 0.000 0.000
2018-03-20 0.000 0.000
2017-06-15 0.050 1.976
2016-04-20 0.055 1.385
2016-03-23 0.055 1.148

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Harmonicare Medical Holdings has not reported any payouts.
  • Unable to verify if Harmonicare Medical Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Harmonicare Medical Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Harmonicare Medical Holdings has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Harmonicare Medical Holdings's dividends in 3 years as they are not expected to pay a notable one for Hong Kong.
X
Income/ dividend checks
We assess Harmonicare Medical Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Harmonicare Medical Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Harmonicare Medical Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Harmonicare Medical Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Yuming Lin
COMPENSATION CN¥519,000
AGE 48
TENURE AS CEO 4.8 years
CEO Bio

Mr. Yuming Lin is the Founder of Bosheng Medical Investment Co., Inc. and has been its Chairman and President since December 2007. Mr. Lin is the Founder, Chairman, CEO and President of Harmonicare Medical Holdings Limited and also has been its Executive Director since August 26, 2014. In 2002, he established Shanxi Modern Women Hospital, the first women hospital in Taiyuan, Shanxi. He served as an Executive Director and General Manager of Beijing Modern Woman Hospital Investment Management Co., Ltd. from July 2004 to March 2012. He served as the General Manager of Shanxi Modern Woman Hospital from August from 2003 to July 2004. He served as an Executive Director of some other members of the Group, such as Wuhan Modern Hospital since December 2005, Guangzhou Woman Hospital since July 2008, Chongqing Wanzhou HarMoniCare Hospital since March 2009, Guiyang HarMoniCare Hospital since May 2009, Chongqing Fuling HarMoniCare Hospital since June 2009, Fuzhou Modern Woman Hospital since January 2010, Shenzhen HarMoniCare Hospital since July 2010, Guiyang Modern Woman Hospital since March 2011, Beijing HarMoniCare Hospital since June 2011, Chongqing Dushi Liren Hospital since August 2013 and Chongqing Modern Woman Hospital since April 2014. Mr. Lin studied in Law at Central China Normal University from March 2008 to January 2010 and obtained a Bachelor's Degree in Business Management in July 2012 through online education.

CEO Compensation
  • Yuming's compensation has increased whilst company is loss making.
  • Yuming's remuneration is lower than average for companies of similar size in Hong Kong.
Management Team Tenure

Average tenure and age of the Harmonicare Medical Holdings management team in years:

1.8
Average Tenure
45
Average Age
  • The average tenure for the Harmonicare Medical Holdings management team is less than 2 years, this suggests a new team.
Management Team

Yuming Lin

TITLE
Chairman
COMPENSATION
CN¥519K
AGE
48
TENURE
4.8 yrs

Wenfeng Li

TITLE
Vice-President of Sourcing and Audit Management
AGE
63
TENURE
1.8 yrs

Jinhui Ren

TITLE
VP & CFO
AGE
42

Zhifeng Fang

TITLE
VP & Executive Director
AGE
44
TENURE
1.8 yrs

Xingli Zhao

TITLE
VP & Executive Director
AGE
45
TENURE
1.8 yrs

Wei Chen

TITLE
VP & Joint Company Secretary
AGE
39

Aries Cheung

TITLE
Joint Company Secretary
AGE
53
TENURE
1.1 yrs
Board of Directors Tenure

Average tenure and age of the Harmonicare Medical Holdings board of directors in years:

4.3
Average Tenure
47
Average Age
  • The tenure for the Harmonicare Medical Holdings board of directors is about average.
Board of Directors

Zhifeng Fang

TITLE
VP & Executive Director
AGE
44
TENURE
4.3 yrs

Xingli Zhao

TITLE
VP & Executive Director
AGE
45
TENURE
4.3 yrs

Aiguo Kong

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥200K
AGE
51
TENURE
4.3 yrs

Yuming Lin

TITLE
Chairman
COMPENSATION
CN¥519K
AGE
48

Lan Fang

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥200K
AGE
47
TENURE
4.3 yrs

Yuguo Lin

TITLE
Non-Executive Director
AGE
45
TENURE
4.3 yrs

Jiang Nan Cai

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥200K
AGE
61
TENURE
4.3 yrs

Jianwei Qiu

TITLE
Non-Executive Director
AGE
42
TENURE
2.5 yrs

Jun Xu

TITLE
Non-Executive Director
AGE
50
TENURE
2.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
X
Management checks
We assess Harmonicare Medical Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Harmonicare Medical Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Why Harmonicare Medical Holdings Limited's (HKG:1509) CEO Pay Matters To You

Yuming Lin became the CEO of Harmonicare Medical Holdings Limited (HKG:1509) in 2014. … This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … According to our data, Harmonicare Medical Holdings Limited has a market capitalization of HK$1.5b, and pays its CEO total annual compensation worth CN¥519k.

Simply Wall St -

Some Harmonicare Medical Holdings (HKG:1509) Shareholders Have Copped A Big 63% Share Price Drop

Because Harmonicare Medical Holdings is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. … In the last three years, Harmonicare Medical Holdings saw its revenue grow by 1.6% per year, compound.

Simply Wall St -

Do Institutions Own Harmonicare Medical Holdings Limited (HKG:1509) Shares?

A look at the shareholders of Harmonicare Medical Holdings Limited (HKG:1509) can tell us which group is most powerful. … Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … Harmonicare Medical Holdings is a smaller company with a market capitalization of HK$1.4b, so it may still be flying under the radar of many institutional investors.

Simply Wall St -

How Should Investors Feel About Harmonicare Medical Holdings Limited's (HKG:1509) CEO Pay?

In 2014 Yuming Lin was appointed CEO of Harmonicare Medical Holdings Limited (HKG:1509). … How Does Yuming Lin's Compensation Compare With Similar Sized Companies. … At the time of writing our data says that Harmonicare Medical Holdings Limited has a market cap of HK$1.3b, and is paying total annual CEO compensation of CN¥519k.

Simply Wall St -

One Thing To Remember About The Harmonicare Medical Holdings Limited (HKG:1509) Share Price

If you're interested in Harmonicare Medical Holdings Limited (HKG:1509), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility).

Simply Wall St -

Should You Buy Harmonicare Medical Holdings Limited (HKG:1509) Now?

Harmonicare Medical Holdings Limited (HKG:1509), a healthcare company based in China,. … As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value? … Let’s take a look at Harmonicare Medical Holdings’s outlook and value based on the most recent financial data to see if the opportunity still exists

Simply Wall St -

Should You Be Concerned About Harmonicare Medical Holdings Limited's (HKG:1509) Shareholders?

In this analysis, my focus will be on developing a perspective on Harmonicare Medical Holdings Limited’s (HKG:1509) latest ownership structure, a less discussed, but important factor. … The impact of a company's ownership structure affects both its short- and long-term performance. … View our latest analysis for Harmonicare Medical Holdings

Simply Wall St -

Should You Sell Harmonicare Medical Holdings Limited (HKG:1509) At This PE Ratio?

and want to better understand how you can grow your money by investing in Harmonicare Medical Holdings Limited (HKG:1509). … Harmonicare Medical Holdings Limited (HKG:1509) is trading with a trailing P/E of 51.3x, which is higher than the industry average of 35.2x. … Check out our latest analysis for Harmonicare Medical Holdings

Simply Wall St -

What You Must Know About Harmonicare Medical Holdings Limited's (SEHK:1509) 4.92% ROE

Check out our latest analysis for Harmonicare Medical Holdings Breaking down ROE — the mother of all ratios Return on Equity (ROE) is a measure of 1509’s profit relative to its shareholders’ equity. … Return on Equity = Net Profit ÷ Shareholders Equity ROE is assessed against cost of equity, which is measured using the Capital Asset Pricing Model (CAPM) – but let’s not dive into the details of that today. … This is called the Dupont Formula: Dupont Formula ROE = profit margin × asset turnover × financial leverage ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity) ROE = annual net profit ÷ shareholders’ equity SEHK:1509 Last Perf Dec 7th 17 The first component is profit margin, which measures how much of sales is retained after the company pays for all its expenses.

Simply Wall St -

Company Info

Description

Harmonicare Medical Holdings Limited, an investment holding company, operates obstetrics and gynecology hospitals that provide inpatient and outpatient healthcare services. The company operates through Specialized Hospital Services, and Supply of Pharmaceuticals and Medical Devices Business segments. It also provides dental and medical beauty services, general outpatient, neonatal intensive care, infant hospitalization, breast milk nutritional analysis, intellectual evaluation and growth guidance, physical examination and assessment, maternity, and other personalized services, as well as operates child health clinics. In addition, the company supplies pharmaceuticals and medical devices. It operates its hospitals under the Harmonicare brand. As of December 31, 2017, the company owned and operated 13 hospitals in 9 first-tier and second-tier cities primarily in the People’s Republic of China. Harmonicare Medical Holdings Limited was founded in 2002 and is headquartered in Beijing, the People’s Republic of China.

Details
Name: Harmonicare Medical Holdings Limited
1509
Exchange: SEHK
Founded: 2002
HK$1,516,689,173
743,475,085
Website: http://www.hemeiyl.com
Address: Harmonicare Medical Holdings Limited
No. A2 Xiaoguan Beili,
Beiyuan Road,
Beijing,
100029,
China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 1509 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 07. Jul 2015
DB 157 Ordinary Shares Deutsche Boerse AG DE EUR 07. Jul 2015
Number of employees
Current staff
Staff numbers
4,083
Harmonicare Medical Holdings employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/26 12:59
End of day share price update: 2019/03/29 00:00
Last estimates confirmation: 2019/06/19
Last earnings filing: 2019/05/07
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.